Anthem has reached a settlement with New York Attorney General Eric Schneiderman to end its policy requiring prior authorization for medication-assisted treatment (MAT) for opioid addiction.

Last year didn’t see healthcare breaches on the scale of the Anthem hack of 2015, but there were still 450 reported breaches in 2016 affecting more than 27 million patient records, as reported in the "Breach Barometer Report: Year in Review” by Protenus.

The ability to reproduce results of published experiments helps prove affectability in future implementation. A major project in measuring the reliability of cancer research has found a lack of reproducibility to be damaging to the advancement of cancer treatments.

Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.

Colorado voters legalized physician-assisted suicide for terminally ill patients last November, but the resistance of the state’s Catholic health systems may make aid-in-dying services difficult to access.

A study of a new HIV neutralizing antibody, 10-1074, has completed its testing in humans. Led by Florian Klein, of the University Hospital Cologne and German Center for Infection Research, the research is published in Nature Medicine. 

Researchers at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York have completed a phase 3 trial on the effectiveness of a drug on advanced liver cancer.

Drug manufacturers have used money to increase their clout with patient advocacy groups, clinical guidelines and physicians, according to a series of commentaries published in JAMA Internal Medicine.